Table of Contents

1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Neutral Alternative Protein Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Plant Protein Market Performance (Volume)
2.1.2 Insect Protein Market Performance (Volume)
2.1.3 Algae Protein Market Performance (Volume)
2.1.4 Others Market Performance (Volume)
2.2 Overall Market Performance(Value)
2.2.1 Plant Protein Market Performance (Value)
2.2.2 Insect Protein Market Performance (Value)
2.2.3 Algae Protein Market Performance (Value)
2.2.4 Others Market Performance (Value)
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Food & Beverage Market Performance (Volume)
3.1.2 Healthcare product Market Performance (Volume)
4 Manufacturers Profiles/Analysis
4.1 Kerry Group
4.1.1 Kerry Group Profiles
4.1.2 Kerry Group Product Information
4.1.3 Kerry Group Neutral Alternative Protein Business Performance
4.1.4 Kerry Group Neutral Alternative Protein Business Development and Market Status
4.2 Cargill
4.2.1 Cargill Profiles
4.2.2 Cargill Product Information
4.2.3 Cargill Neutral Alternative Protein Business Performance
4.2.4 Cargill Neutral Alternative Protein Business Development and Market Status
4.3 Archer Daniels Midland Company
4.3.1 Archer Daniels Midland Company Profiles
4.3.2 Archer Daniels Midland Company Product Information
4.3.3 Archer Daniels Midland Company Neutral Alternative Protein Business Performance
4.3.4 Archer Daniels Midland Company Neutral Alternative Protein Business Development and Market Status
4.4 Glanbia
4.4.1 Glanbia Profiles
4.4.2 Glanbia Product Information
4.4.3 Glanbia Neutral Alternative Protein Business Performance
4.4.4 Glanbia Neutral Alternative Protein Business Development and Market Status
4.5 CHS
4.5.1 CHS Profiles
4.5.2 CHS Product Information
4.5.3 CHS Neutral Alternative Protein Business Performance
4.5.4 CHS Neutral Alternative Protein Business Development and Market Status
4.6 Tereos Syral
4.6.1 Tereos Syral Profiles
4.6.2 Tereos Syral Product Information
4.6.3 Tereos Syral Neutral Alternative Protein Business Performance
4.6.4 Tereos Syral Neutral Alternative Protein Business Development and Market Status
4.7 CP Kelco
4.7.1 CP Kelco Profiles
4.7.2 CP Kelco Product Information
4.7.3 CP Kelco Neutral Alternative Protein Business Performance
4.7.4 CP Kelco Neutral Alternative Protein Business Development and Market Status
4.8 Davisco
4.8.1 Davisco Profiles
4.8.2 Davisco Product Information
4.8.3 Davisco Neutral Alternative Protein Business Performance
4.8.4 Davisco Neutral Alternative Protein Business Development and Market Status
4.9 Meelunie
4.9.1 Meelunie Profiles
4.9.2 Meelunie Product Information
4.9.3 Meelunie Neutral Alternative Protein Business Performance
4.9.4 Meelunie Neutral Alternative Protein Business Development and Market Status
4.10 Danisco (DuPont)
4.10.1 Danisco (DuPont) Profiles
4.10.2 Danisco (DuPont) Product Information
4.10.3 Danisco (DuPont) Neutral Alternative Protein Business Performance
4.10.4 Danisco (DuPont) Neutral Alternative Protein Business Development and Market Status
4.11 MGP Ingredient
4.12 Taj Agro Product
4.13 Glico Nutrition
5 Market Performance for Manufacturers
5.1 Europe Neutral Alternative Protein Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Europe Neutral Alternative Protein Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Europe Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
5.4 Europe Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 Germany Market Performance for Manufacturers
6.1.1 Germany Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 Germany Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 Germany Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 Germany Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 UK Market Performance for Manufacturers
6.2.1 UK Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 UK Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 UK Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 UK Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 France Market Performance for Manufacturers
6.3.1 France Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 France Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 France Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 France Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Russia Market Performance for Manufacturers
6.4.1 Russia Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Russia Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Russia Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Russia Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Benelux Market Performance for Manufacturers
6.5.1 Benelux Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Benelux Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Benelux Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Benelux Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 Italy Market Performance for Manufacturers
6.6.1 Italy Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 Italy Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 Italy Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 Italy Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Spain Market Performance for Manufacturers
6.7.1 Spain Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Spain Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Spain Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Spain Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 Market Performance for Manufacturers
6.8.1 Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Europe Neutral Alternative Protein Market Performance (Sales Point)
7.1 Europe Neutral Alternative Protein Sales (K Units) and Market Share by Regions 2014-2020
7.2 Europe Neutral Alternative Protein Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Europe Neutral Alternative Protein Price (USD/Unit) by Regions 2014-2020
7.4 Europe Neutral Alternative Protein Gross Margin by Regions 2014-2020
8 Development Trend for Regions (Sales Point)
8.1 Europe Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
8.2 Germany Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
8.3 UK Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 France Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
8.5 Russia Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
8.6 Benelux Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
8.7 Italy Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
8.8 Spain Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Food & Beverage Industry
11.2 Healthcare product Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Europe Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Europe Neutral Alternative Protein Sales (K Units) and Growth Rate 2021-2026
12.1.3 Germany Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 UK Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 France Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Russia Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Benelux Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 Italy Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Spain Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Plant Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.3 Insect Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.4 Algae Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.5 Others Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.3 Sales Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Food & Beverage Sales and and Growth Rate 2021-2026
12.3.3 Healthcare product Sales and and Growth Rate 2021-2026
12.4 Price (USD/Unit) and Gross Profit Forecast
12.4.1 Europe Neutral Alternative Protein Price (USD/Unit) Trend 2021-2026
12.4.2 Europe Neutral Alternative Protein Gross Profit Trend 2021-2026
13 Conclusion